Venkataraman Balasubramanian

Array ( [id] => 7319013 [patent_doc_number] => 20040224927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => '7-N-substituted phenyl tetracycline compounds' [patent_app_type] => new [patent_app_number] => 10/820456 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8480 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224927.pdf [firstpage_image] =>[orig_patent_app_number] => 10820456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346921 [patent_doc_number] => 20040192662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Tazarotene and corticosteriod treatment for psoriasis' [patent_app_type] => new [patent_app_number] => 10/820298 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3098 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192662.pdf [firstpage_image] =>[orig_patent_app_number] => 10820298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070110 [patent_doc_number] => 20050245495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Azacyclosteroid histamine-3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/819849 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38548 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245495.pdf [firstpage_image] =>[orig_patent_app_number] => 10819849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145566 [patent_doc_number] => 20050119235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => '7-phenyl-substituted tetracycline compounds' [patent_app_type] => utility [patent_app_number] => 10/819343 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8264 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119235.pdf [firstpage_image] =>[orig_patent_app_number] => 10819343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020090 [patent_doc_number] => 20050222109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Crystalline 19-norsteroids' [patent_app_type] => utility [patent_app_number] => 10/815351 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1173 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222109.pdf [firstpage_image] =>[orig_patent_app_number] => 10815351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7319032 [patent_doc_number] => 20040224935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Topical antiandrogenic steroids' [patent_app_type] => new [patent_app_number] => 10/815515 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9317 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224935.pdf [firstpage_image] =>[orig_patent_app_number] => 10815515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265082 [patent_doc_number] => 20040242618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Antiandrogens with marginal agonist activity and methods of use' [patent_app_type] => new [patent_app_number] => 10/814503 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17283 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242618.pdf [firstpage_image] =>[orig_patent_app_number] => 10814503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020096 [patent_doc_number] => 20050222115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Bile acid derived steroidal dimers with novel amphiphilic topology having antifungal activity' [patent_app_type] => utility [patent_app_number] => 10/815109 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2150 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222115.pdf [firstpage_image] =>[orig_patent_app_number] => 10815109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154899 [patent_doc_number] => 20070037782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Therapeutic agent for ageing macular degeneration' [patent_app_type] => utility [patent_app_number] => 10/573590 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2209 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037782.pdf [firstpage_image] =>[orig_patent_app_number] => 10573590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672912 [patent_doc_number] => 20040180867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Low dose estrogen interrupted hormone replacement therapy' [patent_app_type] => new [patent_app_number] => 10/806613 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6002 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180867.pdf [firstpage_image] =>[orig_patent_app_number] => 10806613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991626 [patent_doc_number] => 20050090663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Steroid spirolactonization' [patent_app_type] => utility [patent_app_number] => 10/806081 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32936 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090663.pdf [firstpage_image] =>[orig_patent_app_number] => 10806081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625907 [patent_doc_number] => 20060264412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Steroid spirolactonization' [patent_app_type] => utility [patent_app_number] => 10/549819 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32797 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264412.pdf [firstpage_image] =>[orig_patent_app_number] => 10549819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325279 [patent_doc_number] => 20040138185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Process for the preparation of 3-glutamido bile ester derivatives using n-prtotected methyl proglutamate' [patent_app_type] => new [patent_app_number] => 10/467204 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4195 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138185.pdf [firstpage_image] =>[orig_patent_app_number] => 10467204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466372 [patent_doc_number] => 20040198711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => '15Alpha-substituted estradiol carboxylic acid esters as locally active estrogens' [patent_app_type] => new [patent_app_number] => 10/796462 [patent_app_country] => US [patent_app_date] => 2004-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18849 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198711.pdf [firstpage_image] =>[orig_patent_app_number] => 10796462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700673 [patent_doc_number] => 20060217358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof' [patent_app_type] => utility [patent_app_number] => 10/548473 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7706 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217358.pdf [firstpage_image] =>[orig_patent_app_number] => 10548473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351627 [patent_doc_number] => 20040248861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Modified delta5-androstenes having improved bioavailability' [patent_app_type] => new [patent_app_number] => 10/785600 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3451 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248861.pdf [firstpage_image] =>[orig_patent_app_number] => 10785600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760725 [patent_doc_number] => 20060211670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates' [patent_app_type] => utility [patent_app_number] => 10/546025 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5862 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211670.pdf [firstpage_image] =>[orig_patent_app_number] => 10546025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596864 [patent_doc_number] => 20060160782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => '2-Substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action' [patent_app_type] => utility [patent_app_number] => 10/546030 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10780 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160782.pdf [firstpage_image] =>[orig_patent_app_number] => 10546030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 394106 [patent_doc_number] => 07297801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-20 [patent_title] => 'Process for the production of 2-oxa-3-one androstane derivatives' [patent_app_type] => utility [patent_app_number] => 10/779519 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1931 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/297/07297801.pdf [firstpage_image] =>[orig_patent_app_number] => 10779519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410137 [patent_doc_number] => 20040176338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Pharmaceutical compositions based on anticholinergics and corticosteroids' [patent_app_type] => new [patent_app_number] => 10/776757 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7766 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176338.pdf [firstpage_image] =>[orig_patent_app_number] => 10776757 [rel_patent_id] =>[rel_patent_doc_number] =>)